Latest Biotech Startup Funding Rounds
Financing for drug discovery, therapeutics and biological technologies, with the development context behind each round.
- Rounds
- 473 All time
- Disclosed funding
- $19.6B 400 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| HA Heritable AgricultureCompany profile Develops AI-driven crop improvement solutions for climate-resilient crops Develops AI-driven crop improvement solutions for climate-resilient crops | $5M | GrantUndisclosed | Biotech, Agritech | United States | Investors | |
| C Develops automated cell therapy manufacturing platforms | $257M | Series DSeries C+ | Biotech | United States | Investors | |
| SB Stellular BioCompany profile Develops platelet-derived regenerative biologic therapeutics for ocular surface diseases Develops platelet-derived regenerative biologic therapeutics for ocular surface diseases | Undisclosed | Series A | Biotech | United States | Investors | |
| TB Develops precision immunoregulatory medicines based on tissue Treg biology | $50M | Undisclosed | Biotech | United States | Investors | |
| N NavidenceCompany profile Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research Provides AI-native platform with standardized computable definitions of diseases and outcomes for real-world evidence research | Undisclosed | Seed | Biotech, Healthtech | United States | Investors | |
| A AntheiaCompany profile Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. Antheia manufactures pharmaceutical ingredients through biosynthesis, using controlled fermentation to supply drugmakers with key starting materials and active ingredients. | $24M | Series C second closeSeries C+ | Biotech | United States | Investors | |
| GK Provides data analysis for quality and regulatory intelligence. | Undisclosed | Pre-SeedPre-seed | Biotech | United States | Investors | |
| BB Barnwell BioCompany profile Provides metagenomic biosurveillance for poultry producers to detect disease threats early Provides metagenomic biosurveillance for poultry producers to detect disease threats early | $6M | Seed | Biotech | United States | Investors | |
| FB Fortitude BiomedicinesCompany profile Develops antibody-based therapies for autoimmune diseases and cancer Develops antibody-based therapies for autoimmune diseases and cancer | $13M | Seed | Biotech | United States | Investors | |
| RM Resolve M TherapeuticsCompany profile Builds pro-resolution platform for target ID and drug discovery for inflammatory diseases Builds pro-resolution platform for target ID and drug discovery for inflammatory diseases | Undisclosed | Undisclosed | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1RA Capital Management
Estuary Biotherapeutics, Circle Pharma, Inc., Solstice Oncology
22rounds3led - 2Janus Henderson Investors
Star Therapeutics, OMass Therapeutics, Soufflé Therapeutics
15rounds1led - 3Eli Lilly and Company
BigHat Biosciences, Circle Pharma, Inc., Moonwalk Biosciences
15rounds0led - 4ARCH Venture Partners
Soufflé Therapeutics, Encoded Therapeutics Inc., Moonwalk Biosciences
14rounds0led - 5OrbiMed
Star Therapeutics, Leal Therapeutics, Accro Bioscience
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.